Moleculin Biotech
MBRX
MBRX
31 hedge funds and large institutions have $5.16M invested in Moleculin Biotech in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $5.31M → $5.16M (-$147K)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$237K | |
| 2 | +$113K | |
| 3 | +$42K | |
| 4 |
Bank of New York Mellon
New York
|
+$41.5K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$31K |
Top Sellers
| 1 | -$86.2K | |
| 2 | -$20K | |
| 3 | -$6.78K | |
| 4 |
ACS
Archford Capital Strategies
Swansea,
Illinois
|
-$4K |